Home › Trial NCT05695508
GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
- Trial IDNCT05695508
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of Heidelberg Medical Center
- Enrollment160
- Start date2022-12-01
- ConditionsMultiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.